“As people live longer, improving quality of life is paramount,” said Alex Morgan, a partner at Khosla Ventures, who chipped in to fund Rubedo’s first round of venture capital financing. “Rubedo is targeting senescent, or aging, cells that drive age-related disease. This first trial can bring us another step closer to achieving better healthspan.”Continue ReadingCategory: Medical, ScienceTags: anti-aging, Disease, Drug, Age-Related, Cells, Regenerative Medicine
Anti-aging biopharma company raises $40 million to begin human tests
Posted by ArielTechGeek 195 days ago (https://newatlas.com)
Who Voted for this Story
Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz
a
adventure
apps
architects
architecture
best
chrome
clear
compelling
comprehensive
design
follow
fun
game
games
google
guide
hidden
home
hosting
house
interserver
ios
its
list
london
money
mysql
nikon
olympics
plenty
projector
providers
review
save
secret
text
top
tops
view
Comments